Boston Scientific Corporation (LON:0HOY)

Boston Scientific Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,275	414	865	928	1,925	1,734
Cash & Short-Term Investments	1,275	414	865	928	1,925	1,734
Cash Growth	-49.04%	-52.14%	-6.79%	-51.79%	11.02%	699.08%
Accounts Receivable	2,828	2,558	2,228	1,970	1,778	1,531
Receivables	2,828	2,558	2,228	1,970	1,778	1,531
Inventory	2,921	2,810	2,484	1,867	1,610	1,351
Restricted Cash	98	111	130	149	188	208
Other Current Assets	913	1,027	807	846	816	1,870
Total Current Assets	8,035	6,920	6,514	5,760	6,317	6,694
Property, Plant & Equipment	4,290	3,743	3,298	2,832	2,687	2,542
Long-Term Investments	642	556	413	407	411	918
Goodwill	18,214	17,089	14,387	12,920	11,988	9,951
Other Intangible Assets	7,162	6,684	6,003	5,969	6,235	6,135
Long-Term Deferred Tax Assets	3,669	3,655	3,841	3,942	4,142	4,210
Other Long-Term Assets	695	748	680	639	449	327
Total Assets	42,707	39,395	35,136	32,469	32,229	30,777
Accounts Payable	1,002	960	942	862	794	513
Accrued Expenses	3,130	2,533	2,136	1,855	1,883	1,666
Current Portion of Long-Term Debt	483	1,778	531	20	261	13
Current Portion of Leases	-	81	76	61	71	70
Current Income Taxes Payable	174	268	220	232	209	158
Current Unearned Revenue	309	306	266	220	208	138
Other Current Liabilities	230	473	762	553	848	1,123
Total Current Liabilities	5,328	6,399	4,933	3,803	4,274	3,681
Long-Term Debt	10,992	8,842	8,566	8,910	8,798	9,123
Long-Term Leases	570	527	395	352	395	408
Long-Term Unearned Revenue	359	329	311	289	276	257
Long-Term Deferred Tax Liabilities	242	155	134	144	310	330
Other Long-Term Liabilities	1,586	1,140	1,267	1,398	1,554	1,652
Total Liabilities	19,077	17,392	15,606	14,896	15,607	15,451
Common Stock	17	17	17	17	17	17
Additional Paid-In Capital	21,419	21,056	20,647	20,289	19,986	19,732
Retained Earnings	4,899	2,673	819	-750	-1,392	-2,378
Treasury Stock	-2,251	-2,251	-2,251	-2,251	-2,251	-2,251
Comprehensive Income & Other	-690	275	50	268	262	206
Total Common Equity	23,394	21,770	19,282	17,573	16,622	15,326
Minority Interest	236	233	248	-	-	-
Shareholders' Equity	23,630	22,003	19,530	17,573	16,622	15,326
Total Liabilities & Equity	42,707	39,395	35,136	32,469	32,229	30,777
Total Debt	12,045	11,228	9,568	9,343	9,525	9,614
Net Cash (Debt)	-10,770	-10,814	-8,703	-8,415	-7,600	-7,880
Net Cash Per Share	-7.21	-7.28	-5.95	-5.84	-5.30	-5.56
Filing Date Shares Outstanding	1,482	1,476	1,467	1,435	1,427	1,417
Total Common Shares Outstanding	1,482	1,475	1,466	1,433	1,426	1,417
Working Capital	2,707	521	1,581	1,957	2,043	3,013
Book Value Per Share	15.78	14.76	13.16	12.26	11.66	10.82
Tangible Book Value	-1,982	-2,003	-1,108	-1,316	-1,601	-760
Tangible Book Value Per Share	-1.34	-1.36	-0.76	-0.92	-1.12	-0.54
Land	147	144	140	137	109	104
Buildings	2,536	2,019	1,843	1,695	1,523	1,292
Machinery	4,037	3,629	3,503	3,298	3,288	3,466
Construction In Progress	936	1,035	857	598	605	446

Source: S&P Global Market Intelligence. Standard template. Financial Sources.